Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity‐associated NAFLD
Background and Aims Fatty liver is common in obesity as well as in partial lipodystrophy (PL) syndromes, characterized by deficient adipose tissue. Insulin resistance is key to fatty liver pathogenesis in both entities. We aimed to compare the contributions of insulin resistance and adipose tissue t...
Gespeichert in:
Veröffentlicht in: | Liver international 2023-12, Vol.43 (12), p.2692-2700 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background and Aims
Fatty liver is common in obesity as well as in partial lipodystrophy (PL) syndromes, characterized by deficient adipose tissue. Insulin resistance is key to fatty liver pathogenesis in both entities. We aimed to compare the contributions of insulin resistance and adipose tissue to hepatic steatosis in PL and non‐syndromic, obesity‐associated non‐alcoholic fatty liver disease (NS‐NAFLD).
Methods
In a cross‐sectional comparison of people with NS‐NAFLD (N = 73) and PL (N = 27), liver fat was measured by FibroScan® controlled attenuation parameter (CAP) and insulin resistance by HOMA‐IR, Adipo‐IR, and NMR‐based LP‐IR.
Results
Insulin resistance was greater in PL versus NS‐NAFLD by HOMA‐IR (p = 0.005), Adipo‐IR (p = 0.01) and LP‐IR (p = 0.05) while liver fat was comparable (304 vs. 324 dB/m, p = 0.12). Liver fat correlated with HOMA‐IR in both groups, but CAP values were lower by 32 dB/m in PL compared with NS‐NAFLD for any given HOMA‐IR. In contrast, Adipo‐IR and LP‐IR correlated with CAP only in the NS‐NAFLD group, suggesting different pathways for fat accumulation. Plasma free fatty acids, reflecting substrate input from the adipose tissue, were comparable between groups. However, the levels of β‐hydroxybutyrate, a marker of β‐oxidation, and large triglyceride‐rich lipoprotein particles, a marker of VLDL secretion, were both higher in PL (p |
---|---|
ISSN: | 1478-3223 1478-3231 |
DOI: | 10.1111/liv.15707 |